Data / Drug companies / Medical Group Care LLC
Medical Group Care LLC: 24 products in the FDA NDC directory, labeler code 83173
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Medical Group Care LLC (labeler code 83173) lists 24 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 24 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on May 25, 2026.
The request: Watch Medical Group Care LLC (FDA labeler code 83173): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83173
- Products in commercial distribution
- 24
- Packages
- 31
- Finished drugs by generic name
- 12
- Prescription products
- 0
- Over the counter products
- 24
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- February 12, 2023
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 24 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lozenge | 16 | 66.7% |
| Tablet | 5 | 20.8% |
| Tablet, chewable, extended release | 2 | 8.3% |
| Tablet, chewable | 1 | 4.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Blood Coagulation Factor | 6 |
| Phosphate Binder | 6 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| MGC Health Cough Drops Honey Lemon Flavor | 83173-101 | Lozenge | Over the counter monograph drugs | May 25, 2026 |
| MGC Health Cough Drops Honey Herb | 83173-143 | Lozenge | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Calcium Carbonate Antacid Tropical Fruit | 83173-138 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Calcium Carbonate Antacid Assorted Berries | 83173-137 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Calcium Carbonate Antacid Assorted Fruits | 83173-136 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Calcium Carbonate Antacid Assorted Fruits | 83173-135 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Calcium Carbonate Antacid Assorted Berries | 83173-134 | Tablet | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Cough Drops Honey Herb | 83173-133 | Lozenge | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Drops Sugar Free Lemon Mint | 83173-132 | Lozenge | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Cough Drops Original Herb | 83173-131 | Lozenge | Over the counter monograph drugs | August 12, 2025 |
| MGC Health Throat Soothing Drops Creamy Strawberry | 83173-120 | Lozenge | Over the counter monograph drugs | July 29, 2025 |
| MGC Health Antacid Soft Chews Cherry Flavor | 83173-130 | Tablet, chewable | Over the counter monograph drugs | October 10, 2024 |
| MGC Cough Drops | 83173-109 | Lozenge | Over the counter monograph drugs | June 21, 2024 |
| MGC Health | 83173-129 | Lozenge | Over the counter monograph drugs | September 1, 2023 |
| MGC Health | 83173-128 | Lozenge | Over the counter monograph drugs | September 1, 2023 |
| MGC Health | 83173-127 | Lozenge | Over the counter monograph drugs | September 1, 2023 |
| MGC Health | 83173-126 | Lozenge | Over the counter monograph drugs | July 1, 2023 |
| MGC Health | 83173-121 | Lozenge | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-117 | Tablet, chewable, extended release | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-116 | Tablet, chewable, extended release | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-115 | Lozenge | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-114 | Lozenge | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-113 | Lozenge | Over the counter monograph drugs | February 12, 2023 |
| MGC Health | 83173-100 | Lozenge | Over the counter monograph drugs | February 12, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.